Manubens A, Paiva B, Gutierrez NC, Fernandez M, Calasanz MJ, Rosinol L, Oriol A, Blanchard MJ, Carrillo E, Benavente C, Martinez-Lopez J, Bargay J, Hernandez MT, de la Rubia J, Gonzalez Y, Paricio M, de Arriba F, Ocio EM, Teruel AI, de la Guia AL, Sirvent M, Gironella M, Sampol A, Arguinano JM, Cabrera C, Alegre A, Granell M, Cabanas V, Nunez-Cordoba JM, Mateos MV, Lahuerta JJ, San Miguel JF, Blade J, Rodriguez-Otero P. High-risk features of early relapse in newly-diagnosed multiple myeloma: The impact of cytogenetics and response to initial therapy. Hemasphere. 2025 Apr 24;9(4):e70127. doi: 10.1002/hem3.70127. eCollection 2025 Apr. PubMed PMID: 40276216; PubMed Central PMCID: PMC12020018.
AÑO: 2025; IF: 14.6